To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
10 Current companies
rssCambridge Biotechnology Ltd (CBT) is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously...
pharmaceutical companies such as Pfizer, Merck, and AstraZeneca, as well as smaller research collaborations with mid-size pharmaceutical and biotech companies. ...
, in phase 2 for type 2 diabetes. NicOx has strategic partnerships with some of the world's leading pharmaceutical companies, including Pfizer Inc. and Merck & Co., Inc. NicOx S.A. is headquartered in Sophia...
possesses one of the most diverse fragment libraries. Graffinity has established collaborations with many partners including Amgen, Boehringer-Ingelheim, Genentech, Pfizer and Genentech....
in the Xalatan® project of Pharmacia. Xalatan®, with 1.3 billion US dollar sales in 2004, acquired by Pfizer, was the first prostaglandin analogue developed for glaucoma treatment. Johan Stjernschantz, Professor...
therapies are at the cutting edge of oncology drugs following the Gleevec lead (sales of 2.9 billion US$ in 2007). The recent successes of Nexavar (Astra Zeneca), Sprycel (BMS), Sutent (Pfizer) and Tykerb...
